Table 1.
1. HCV Prevalence 2012 BC population: 4,542,508 The literature reports a range of 20–44% HCV undiagnosed. Among linked cohort members alive on Dec. 31, 2012, there were 54,902 HCV Diagnosed (1.2% of the 2012 BC population) From this number, we added 25% undiagnosed, or 73,203 anti-HCV positive persons living in BC in 2012 (1.6% of the 2012 BC population) |
2. HCV Diagnoseda On or before Dec. 31, 2012:
|
3. HCV RNA Tested At least one HCV RNA (PCR) test on record on or before Dec. 31, 2012 |
3a. HCV RNA Negative Among HCV Diagnosed individuals with no dispensation of interferon-based antivirals (untreated), the last HCV RNA test on record on or before Dec. 31, 2012 is negative. These individuals are considered not actively infected/non-viraemic |
4. HCV Genotyped At least one valid genotype test result on record on or before Dec. 31, 2012 |
5. Initiated HCV Antiviral Treatment Dispensation, on or before Dec. 31, 2012, of interferon-based antivirals specific to HCV treatmentb |
6. Estimated SVRc Among treated individuals:
|
NB: 1361(16.0%) treated individuals lacked adequate HCV RNA data in the timeframe of interest to be assessed for SVR.
Earliest available laboratory testing data (1992), reportable disease data (1990), and drug dispensation data (2000).
Drug Information Number/Product Identification Number (DINPIN): 2254603, 2254638, 2254646, 2371448, 2371456, 2371464, 2371472, 2371553, 2370816, 2241159, 2239730, 2246030, 2246028, 2246029, 2246027, 2246026, 2253410, 2253429, 2254581.
HCV RNA data up to Dec. 31st, 2013 was included to allow assessment of SVR for 2012 treatment starts.